• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

教育水平、管理与小细胞肺癌(SCLC)结局:基于人群的队列研究。

Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.

机构信息

Department of Oncology and Pathology, Karolinska Institutet, Stockholm, Sweden.

Regional Cancer Center, Uppsala, Sweden.

出版信息

Lung Cancer. 2020 Jan;139:111-117. doi: 10.1016/j.lungcan.2019.11.008. Epub 2019 Nov 14.

DOI:10.1016/j.lungcan.2019.11.008
PMID:31760352
Abstract

OBJECTIVES

To examine if educational status is associated with outcome in patients with Small Cell Lung Cancer (SCLC). The study also investigated differences in patterns of management (lead times and treatment intensity) between educational levels.

MATERIAL AND METHODS

This nationwide cohort study was based on data from Lung Cancer Data Base Sweden (LCBaSe) generated by record linkages between the Swedish National Lung Cancer Register and several other population-based registers. Educational level was categorized by number of years of schooling: low (≤ 9 years), medium (10-12 years) and high (≥ 13 years). Risk of death expressed as hazard ratios (HR) with 95 % confidence interval (CI) were estimated in multi-variable analyses adjusted for age, sex, disease stage at diagnosis, household size and performance status (PS). Analyses stratified by sex and stage were also performed.

RESULTS AND CONCLUSIONS

The study population encompassed 4256 patients with an SCLC diagnosis between 2002 and 2011. Higher education was associated with a significantly lower risk of death in univariable and multivariable models. The univariable HR comparing high to low level of education was 0.84 (95 % CI: 0.75-0.93), an estimate that was attenuated following adjustments (HR 0.88; 95 % CI: 0.80-0.98). Compared to men with a low level of education, the risk of death was significantly lower in men with a high education; HR 0.84 (95 % CI: 0.73-0.98). In Limited Disease (LD), the prognosis was significantly better in both men and women with high compared low education (HR 0.76; 95 % CI: 0.58-0.98). In Swedish men with SCLC, and among patients with LD-SCLC, a low level of education was associated with a poorer prognosis compared to patients with high education.

摘要

目的

研究教育程度与小细胞肺癌(SCLC)患者预后的相关性。本研究还调查了不同教育水平之间管理模式(就诊时间和治疗强度)的差异。

材料和方法

本全国性队列研究基于瑞典肺癌数据库(LCBaSe)的数据,该数据库是通过瑞典国家肺癌登记处与其他几个基于人群的登记处之间的记录链接生成的。教育程度按受教育年限分类:低(≤9 年)、中(10-12 年)和高(≥13 年)。采用多变量分析,调整年龄、性别、诊断时的疾病分期、家庭规模和表现状态(PS),以危险比(HR)表示死亡风险,并计算 95%置信区间(CI)。还按性别和分期进行了分层分析。

结果和结论

本研究人群包括 2002 年至 2011 年间诊断为 SCLC 的 4256 例患者。在单变量和多变量模型中,较高的教育程度与死亡风险显著降低相关。与低教育程度相比,高教育程度的单变量 HR 为 0.84(95%CI:0.75-0.93),调整后(HR 0.88;95%CI:0.80-0.98)有所减弱。与低教育程度的男性相比,高教育程度的男性死亡风险显著降低,HR 为 0.84(95%CI:0.73-0.98)。在局限性疾病(LD)中,高教育程度的男性和女性患者的预后明显优于低教育程度的患者(HR 0.76;95%CI:0.58-0.98)。在瑞典男性 SCLC 患者中,以及 LD-SCLC 患者中,与高教育程度的患者相比,低教育程度与较差的预后相关。

相似文献

1
Educational level, management and outcomes in small-cell lung cancer (SCLC): A population-based cohort study.教育水平、管理与小细胞肺癌(SCLC)结局:基于人群的队列研究。
Lung Cancer. 2020 Jan;139:111-117. doi: 10.1016/j.lungcan.2019.11.008. Epub 2019 Nov 14.
2
Educational level and management and outcomes in non-small cell lung cancer. A nationwide population-based study.教育水平与非小细胞肺癌的管理和结局。一项全国范围内基于人群的研究。
Lung Cancer. 2019 May;131:40-46. doi: 10.1016/j.lungcan.2019.03.004. Epub 2019 Mar 7.
3
Clinical predictors of survival in young patients with small cell lung cancer: Results from the California Cancer Registry.年轻小细胞肺癌患者生存的临床预测因素:来自加利福尼亚癌症登记处的结果。
Lung Cancer. 2017 Oct;112:165-168. doi: 10.1016/j.lungcan.2017.08.015. Epub 2017 Aug 31.
4
Epidemiology, treatment, and survival in small cell lung cancer in Spain: Data from the Thoracic Tumor Registry.西班牙小细胞肺癌的流行病学、治疗和生存情况:来自胸肿瘤登记处的数据。
PLoS One. 2021 Jun 2;16(6):e0251761. doi: 10.1371/journal.pone.0251761. eCollection 2021.
5
Comorbidity in Patients With Small-Cell Lung Cancer: Trends and Prognostic Impact.小细胞肺癌患者的合并症:趋势与预后影响
Clin Lung Cancer. 2015 Jul;16(4):282-91. doi: 10.1016/j.cllc.2014.12.003. Epub 2014 Dec 11.
6
Treatment patterns and survival outcomes for small-cell lung cancer patients - a Swedish single center cohort study.小细胞肺癌患者的治疗模式和生存结局 - 一项瑞典单中心队列研究。
Acta Oncol. 2020 Apr;59(4):388-394. doi: 10.1080/0284186X.2019.1711165. Epub 2020 Jan 7.
7
Cardiovascular comorbidities and their prognostic value in small cell lung cancer patients with chemoradiotherapy.放化疗治疗的小细胞肺癌患者的心血管合并症及其预后价值。
Clin Transl Oncol. 2024 Jun;26(6):1348-1356. doi: 10.1007/s12094-023-03359-3. Epub 2023 Dec 16.
8
Barriers to Combined-Modality Therapy for Limited-Stage Small Cell Lung Cancer.局限期小细胞肺癌的联合治疗障碍。
JAMA Oncol. 2018 Aug 1;4(8):e174504. doi: 10.1001/jamaoncol.2017.4504. Epub 2018 Aug 9.
9
Association of Race, Socioeconomic Factors, and Treatment Characteristics With Overall Survival in Patients With Limited-Stage Small Cell Lung Cancer.种族、社会经济因素和治疗特征与局限期小细胞肺癌患者总生存的关系。
JAMA Netw Open. 2021 Jan 4;4(1):e2032276. doi: 10.1001/jamanetworkopen.2020.32276.
10
Prognostic factors differ by tumor stage for small cell lung cancer: a pooled analysis of North Central Cancer Treatment Group trials.小细胞肺癌的预后因素因肿瘤分期而异:北中部癌症治疗组试验的汇总分析
Cancer. 2009 Jun 15;115(12):2721-31. doi: 10.1002/cncr.24314.

引用本文的文献

1
Role of patient characteristics in adherence to first-line treatment guidelines in breast, lung and prostate cancer: insights from the Nordic healthcare system.患者特征在乳腺癌、肺癌和前列腺癌一线治疗指南依从性中的作用:来自北欧医疗体系的见解。
BMJ Open. 2024 Apr 8;14(4):e084689. doi: 10.1136/bmjopen-2024-084689.
2
Value of plasma vitamin D level and nomogram model for predicting the prognosis of patients with small cell lung cancer treated with platinum plus etoposide as first-line chemotherapy.血浆维生素D水平及列线图模型对接受铂类联合依托泊苷一线化疗的小细胞肺癌患者预后的预测价值
Am J Transl Res. 2022 Nov 15;14(11):7771-7781. eCollection 2022.
3
NAVIGATE: improving survival in vulnerable patients with lung cancer through nurse navigation, symptom monitoring and exercise - study protocol for a multicentre randomised controlled trial.
NAVIGATE 研究:通过护士导航、症状监测和运动改善肺癌脆弱患者的生存状况——一项多中心随机对照试验的研究方案。
BMJ Open. 2022 Oct 31;12(10):e060242. doi: 10.1136/bmjopen-2021-060242.
4
Association of Rurality With Annual Repeat Lung Cancer Screening in the Veterans Health Administration.农村地区与退伍军人健康管理局年度重复肺癌筛查的关联。
J Am Coll Radiol. 2022 Jan;19(1 Pt B):131-138. doi: 10.1016/j.jacr.2021.08.027.
5
Racial and Other Healthcare Disparities in Patients With Extensive-Stage SCLC.广泛期小细胞肺癌患者的种族及其他医疗保健差异
JTO Clin Res Rep. 2020 Oct 20;2(1):100109. doi: 10.1016/j.jtocrr.2020.100109. eCollection 2021 Jan.